Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9005225 | Clinical Therapeutics | 2005 | 11 Pages |
Abstract
These results suggest that escitalopram is a cost-saving alternative to citalopram for the treatment of severe depression in the United Kingdom from the perspectives of both the NHS and society. Therefore, a possible advantage may exist at the population level in the treatment of severe depression with escitalopram in the United Kingdom.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Alan G. MB, ChB, FPCA, Idris BS, Michiel E.H. Drs, MSc,